| | |
Baseline Hemoglobin < 10 g/dL
|
Baseline Hemoglobin ≥10 g/dL
|
|---|
| | |
Darbepoetin alfa 500 mcg Q3W
|
Darbepoetin alfa 2.25 mcg/kg QW
|
Darbepoetin alfa 500 mcg Q3W
|
Darbepoetin alfa 2.25 mcg/kg QW
|
|---|
|
Firsta transfusion during week 5 to EOTP
|
Hb ≤8 g/dL, n (%)
|
30 (56)
|
29 (46)
|
12 (55)
|
12 (39)
|
| |
Hb > 8 g/dL, n (%)
|
24 (44)
|
34 (54)
|
10 (45)
|
19 (61)
|
|
Firsta transfusion during week 1 to EOTP
|
Hb ≤8 g/dL, n (%)
|
42 (58)
|
30 (38)
|
9 (39)
|
14 (35)
|
| |
Hb > 8 g/dL, n (%)
|
30 (41)
|
48 (62)
|
14 (61)
|
24 (60)
|
| |
Hb missing, n (%)
|
1 (1)
|
0 (0)
|
0 (0)
|
2 (5)
|
- Q3W = every three weeks; QW = weekly; EOTP = end of the treatment period (defined as the earlier of day 109 or end of study); Hb = hemoglobin; n = number of transfusion events. Note that as data described are for first transfusion only, n also equals the number of patients with at least one transfusion.
-
aThe closest hemoglobin value on the day of transfusion or within 7 days prior was used.
